The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma
Molecules · 2023
DOI: 10.3390/molecules28093705 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Zhenshengnan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun 130021, China. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 9, Thyroid Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Developing Foundation of Jilin province, Beijing Cihua Medical Development Foundation.
Abstract (Originalsprache)
Matrix metalloproteinase-9 (MMP-9), one of the most investigated and studied biomarkers of the MMPs family, is a zinc-dependent proteolytic metalloenzyme whose primary function is degrading the extracellular matrix (ECM). It has been proved that MMP-9 expression elevates in multiple pathological conditions, including thyroid carcinoma. MMP-9 has a detectable higher level in malignant or metastatic thyroid tumor tissues than in normal or benign tissues and acts as an additional marker to distinguish different tumor stages because of its close correlations with clinical features, such as lymph node metastasis, TNM stage, tumor size and so on. Natural and non-natural MMP-9 inhibitors suppress its expression, block the progression of diseases, and play a role in therapy consequently. MMP-9 inhibitory molecules also assist in treating thyroid tumors by suppressing the proliferation, invasion, migration, metastasis, viability, adhesion, motility, epithelial-mesenchymal transition (EMT), and other risk factors of different thyroid cancer cells. In a word, discovering and designing MMP-9 inhibitors provide great therapeutic effects and promising clinical values in various types of thyroid carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun 130021, China.
Förderung
- Science and Technology Developing Foundation of Jilin province
- Beijing Cihua Medical Development Foundation
Zitieren
APA
Li, Z., Wei, J., Chen, B., Wang, Y., Yang, S., Wu, K., & Meng, X. (2023). The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma. Molecules. https://doi.org/10.3390/molecules28093705
Vancouver
Li Z, Wei J, Chen B, Wang Y, Yang S, Wu K, et al. The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma. Molecules. 2023. doi:10.3390/molecules28093705
BibTeX
@article{Li2023,
author = {Li, Zhenshengnan and Wei, Jia and Chen, Bowen and Wang, Yaoqi and Yang, Shuai and Wu, Kehui and Meng, Xianying},
title = {The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28093705}
}
EUVIMED